Kidney Disease & Type 2 Diabetes

High blood glucose levels can damage the glomerulus and lead to thickening of the glomerular basement membrane, over time resulting in kidney deterioration and failure. At present, there is no cure. Here is the latest research on kidney diseases in individuals with type 2 diabetes.

January 16, 2021
Open Access

Sodium-Glucose Cotransporter (SGLT2) inhibitors: A new Era in renovascular protection

International Journal of Cardiology. Hypertension
Adel E Berbari
January 16, 2021

Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis

Diabetology & Metabolic Syndrome
Wanwan LuoZaixing Yang
January 14, 2021
Open Access

Comparison of urinary extracellular vesicle isolation methods for transcriptomic biomarker research in diabetic kidney disease

Journal of Extracellular Vesicles
Karina BarreiroHarry Holthofer
January 15, 2021
Open Access

Clinical Characteristics, Residual Beta-Cell Function and Pancreatic Auto-Antibodies in Thai people with Long-Standing Type 1 Diabetes Mellitus

Journal of the ASEAN Federation of Endocrine Societies
Yotsapon ThewjitcharoenThep Himathongkam
January 17, 2021
Open Access

Peptidomic Analysis of Urine from Youths with Early Type 1 Diabetes Reveals Novel Bioactivity of Uromodulin Peptides In Vitro

Molecular & Cellular Proteomics : MCP
Julie A D VanAna Konvalinka
January 15, 2021
Review

Diabetes and COVID-19: A Review

Journal of the ASEAN Federation of Endocrine Societies
Arjun BaidyaAnand Shankar
January 13, 2021
Review
Open Access

Sodium-glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes

Cardiovascular Diabetology
Dario GiuglianoKatherine Esposito
January 15, 2021
Review
Open Access

How Do I Manage Hypertension in Patients with Advanced Chronic Kidney Disease Not on Dialysis? Perspectives from Clinical Practice

Vascular Health and Risk Management
Erietta PolychronopoulouMichel Burnier
January 16, 2021
Open Access

Pectin-Lyase-Modified Ginseng Extract and Ginsenoside Rd Inhibits High Glucose-Induced ROS Production in Mesangial Cells and Prevents Renal Dysfunction in db/db Mice

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Eunsoo JungJunghyun Kim
January 13, 2021

Salvia Miltiorrhiza in Anti-diabetic Angiopathy

Current Molecular Pharmacology
Zequn YinJihong Han
January 12, 2021
Review

Cataract and systemic disease: A review

Clinical & Experimental Ophthalmology
Michael J Ang, Natalie A Afshari
January 15, 2021

Sodium--glucose co-transporter-2 inhibitors for patients with diabetic and nondiabetic chronic kidney disease: a new era has already begun

Journal of Hypertension
Pantelis Sarafidis‘Hypertension and the Kidney’ working group of the European Society of Hypertension (ESH) and the ‘European Renal and Cardio

Sign up to follow this feed and discover related papers.

Related Feeds

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

COVID-19 & Diabetes (ADA)

COVID-19 (short for “Coronavirus Disease 2019") is the disease caused by the novel coronavirus, SARS-CoV-2. Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes. To keep our community as informed as possible, the American Diabetes Association is partnering with the Chan Zuckerberg Initiative's Meta to highlight the latest research developments at the intersection of COVID-19 and diabetes.

© 2021 Meta ULC. All rights reserved
/feed-previews/kidney-disease-type-2-diabetes/20eeaa50-8cd2-4595-8d81-fe83487eedeb